Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00097682 · ClinicalTrials.gov registry record

Views of Cancer Patients Regarding Financial Conflicts of Interest

A clinical trial of Neoplasms, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
300
Enrollment target
5
Study locations

NCT00097682 is a study of Neoplasms that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 300 participants, below the 1,619-participant average among 158 other Neoplasms trials with a reported enrollment target (81% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00097682, a study of Neoplasms, has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
300 participants
Enrollment target
5
Study locations

Study Summary

This study will explore what research patients understand about financial collaborations in the research setting and their concerns about these collaborations. Financial partnerships are crucial to advancing medical research; however, they are giving rise to increasing concerns about financial conflicts of interest and possible impacts on the integrity of research and patient safety. This study will examine patients' views about financial ties between drug companies and the doctors running research studies, as well as ties between the drug companies and the cancer centers where the studies are conducted. Patients 18 years of age and older who are enrolled in cancer studies at the National Cancer Institute in Bethesda, MD; the Fred Hutchinson Cancer Research Center in Seattle, WA; the Dana-Farber Cancer Institute in Boston, MA; the Columbia Comprehensive University Herbert Irving Cancer Center in New York, NY; and the University of Colorado Cancer Center in Denver, CO, may be eligible for this study. Participants are interviewed about the following: * Patients' awareness and understanding about individual and institutional financial conflicts of interest, and how such conflicts, if they exist, are being managed * The impact of a researcher's financial ties on the patient's decision to participate in that researcher's study * The impact of the institution's financial ties on the patient's decision to participate in research at that institution * Attitudes about policies and practices regarding conflicts of interest in the research setting * Attitudes about disclosure of conflicts of interest in the research setting * Patient symptoms and performance * Patient's cancer trial * Patient's cancer history * Patient's trust * Patient demographics (gender, age, race, religion, education, income, health insurance, employment).

Conditions Studied

Study Locations (5)

Colorado

  • University of Colorado Cancer Center - Denver

Connecticut

  • Yale University - New Haven

Massachusetts

  • Dana Farber Cancer Institute - Boston

New York

  • Columbia University - New York

Washington

  • Fred Hutchinson Cancer Research Center - Seattle

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2004-11-18
Est. Completion 2007-10-02

What the Registry Record Tells You About NCT00097682

The ClinicalTrials.gov registry entry for NCT00097682 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,619-participant average among 158 other Neoplasms trials with a reported enrollment target (81% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 0 interventions.

NCT00097682 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Colorado, Connecticut, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00097682 about?

NCT00097682 is a clinical study titled "Views of Cancer Patients Regarding Financial Conflicts of Interest". This study will explore what research patients understand about financial collaborations in the research setting and their concerns about these collaborations. Financial partnerships are crucial to advancing medical research; however, they are giving rise to increasing concerns about financial confl...

What is the current status of trial NCT00097682?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2004-11-18. Estimated completion is 2007-10-02.

What conditions does trial NCT00097682 study?

This clinical trial studies the following conditions: Neoplasms.

Who is sponsoring clinical trial NCT00097682?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00097682 being conducted?

This trial has 5 study locations across Colorado, Connecticut, Massachusetts, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.